Survival disparities among racial groups with hepatic malignant tumors

doi:10.4251/wjgo.v16.i7.2999

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (203)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

147

Figures (1-2)

Tables (1-5)

Sum=191

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=4

Jul 15, 2024 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2999-3010
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2999

Survival disparities among racial groups with hepatic malignant tumors

Deng Han, Zhi-Yu Zhang, Jin-Yan Deng, Hong-Bo Du

Deng Han, Jin-Yan Deng, Hong-Bo Du, Division of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China

Deng Han, Jin-Yan Deng, Beijing University of Chinese Medicine, Beijing 100105, China

Zhi-Yu Zhang, Department of Rehabilitation, Cangzhou Central Hospital, Cangzhou 061017, Hebei Province, China

Author contributions: Han D had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis; Zhang ZY and Deng JY provided data organization and statistical analysis; Du HB designed the study and critically revised the manuscript; All authors read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Hong-Bo Du, MD, PhD, Doctor, Division of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Haiyuncang, Dongcheng District, Beijing 100700, China. 20220941183@bucm.edu.cn

Received: February 17, 2024
Revised: April 25, 2024
Accepted: May 15, 2024
Published online: July 15, 2024
Processing time: 146 Days and 3.1 Hours

Core Tip

Core Tip: The study's findings suggest that patients with hepatic malignant tumors of Asian descent have a more favorable prognosis compared to those of African descent who face a worse prediction. The factors that impact the prognosis of hepatic malignant tumors vary among different races. Racial disparities are evident in liver cancer treatment and survival prognosis. The primary causes for these disparities include socioeconomic status, autoimmune factors, and geographic location. Understanding the influence of racial disparities on hepatic malignant tumors can enhance comprehension of its pathogenesis, facilitate the provision of tailored treatment and prognosis, and offer guidance for the management of patients.